SoftBank's Surgical Robotics Gamble on China The recent announcement from Noah Medical, a US headquartered surgical robotics firm backed by SoftBank, has significant implications for the burgeoning field of medical technology in Asia.
The company plans to list on the Hong Kong stock exchange as early as next year, with the goal of raising over $100 million.
This move comes amidst a surge of tech listings in the city, but what's driving Noah Medical's decision to tap into China's vast market?